Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Lupromax Pelumas Indonesia Tbk. (LMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Lupromax Pelumas Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Lupromax Pelumas Indonesia Tbk. trades at Rp118 (market cap 77.35B, 1.43M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4× Lupromax Pelumas Indonesia Tbk.'s market cap, and Lupromax Pelumas Indonesia Tbk. is more actively traded (1.43M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | LMAX | |
|---|---|---|
Market Cap | 310.75B | 77.35B |
Volume | 963.6K | 1.43M |
Lot | 9.64K | 14.32K |
Turnover | 217.67M | 165.87M |
Average Price | 225.89 | 115.81 |
Value | 217.67M | 165.87M |
Indicative Equilibrium Price | 226 | 118 |
Indicative Equilibrium Volume | 1K | 2K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Lupromax Pelumas Indonesia Tbk.
PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Read more on LMAX →
